Does influenza vaccination reduce major adverse cardiovascular events in high-risk patients?
Influenza vaccination is associated with a significantly lower risk of major adverse cardiovascular events, particularly in patients with recent ACS.
In this study, receipt of influenza vaccination was associated with a 34% lower risk of major adverse cardiovascular events, and individuals with recent ACS had a 45% lower risk. Given influenza poses a threat to population health during the COVID-19 pandemic, it is integral to counsel high-risk patients on the cardiovascular benefits of influenza vaccination.
Behrouzi et al. (Fri,) studied this question.